Literature DB >> 21745279

All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study.

Kate M Fleming1, Guruprasad P Aithal, Tim R Card, Joe West.   

Abstract

BACKGROUND: Mortality due to cirrhosis has tripled over the last 30 years in the UK. However, we lack adequate, contemporary, population-based estimates of the excess mortality patients who are at risk compared with the general population. AIM: To determine the overall survival in patients with cirrhosis compared with the general population taking into account the effects of severity and aetiology of disease and comorbidity.
METHODS: In a cohort study, we identified 4537 people with cirrhosis and a control cohort of 44 403 patients, matched by age, sex and general practice from the UK General Practice Research Database between June 1987 and April 2002.
RESULTS: Patients with compensated cirrhosis had a nearly five-fold [hazard ratio (HR) 4.7, 95% confidence interval (CI) 4.4-5.0] increased risk of death, while those with decompensated cirrhosis had a near 10-fold (HR 9.7, 95% CI 8.9-10.6) increased risk compared with the general population. Alcoholic cirrhosis conferred a worse prognosis than non-alcohol-related cirrhosis both in the first year following diagnosis and subsequently.
CONCLUSION: Having a diagnosis of cirrhosis confers a substantial increased mortality risk compared with the general population, even for those with compensated disease, with 5-year survival between that seen for breast and colorectal cancer.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21745279     DOI: 10.1111/j.1478-3231.2011.02517.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  41 in total

Review 1.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

Review 2.  Natural history of cirrhosis.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Curr Gastroenterol Rep       Date:  2013-02

Review 3.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

4.  Liver cirrhosis and cancer: comparison of mortality.

Authors:  Wankyo Chung; Changik Jo; Woo Jin Chung; Dong Joon Kim
Journal:  Hepatol Int       Date:  2018-03-01       Impact factor: 6.047

Review 5.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

Review 6.  Magnetic resonance elastography of abdomen.

Authors:  Sudhakar Kundapur Venkatesh; Richard L Ehman
Journal:  Abdom Imaging       Date:  2015-04

Review 7.  Comorbidity in cirrhosis.

Authors:  Peter Jepsen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Role of magnetic resonance elastography in compensated and decompensated liver disease.

Authors:  Sumeet K Asrani; Jayant A Talwalkar; Patrick S Kamath; Vijay H Shah; Giovanna Saracino; Linda Jennings; John B Gross; Sudhakar Venkatesh; Richard L Ehman
Journal:  J Hepatol       Date:  2013-12-19       Impact factor: 25.083

Review 9.  Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency.

Authors:  Karim Hamesch; Pavel Strnad
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 10.  Acute-on-chronic liver failure.

Authors:  Sumeet K Asrani; Jacqueline G O'Leary
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.